BioMarin
Trade BioMarin 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMRN
BioMarin Pharmaceutical, Inc. is a global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. The company has a proven track record of innovation, with nine commercial therapies and a strong clinical and preclinical pipeline.
BMRN Key Statistics
Stock Snapshot
BioMarin(BMRN) stock is priced at $59.97, giving the company a market capitalization of 11.6B. It carries a P/E multiple of 43.60.
On 2026-07-09, BioMarin(BMRN) stock traded between a low of $58.45 and a high of $60.51. Shares are currently priced at $59.97, which is +2.6% above the low and -0.9% below the high.
BioMarin(BMRN) shares are trading with a volume of 876K, against a daily average of 1.94M.
In the last year, BioMarin(BMRN) shares hit a 52-week high of $66.28 and a 52-week low of $49.26.
In the last year, BioMarin(BMRN) shares hit a 52-week high of $66.28 and a 52-week low of $49.26.
BMRN News
BioMarin Pharmaceutical (BMRN) was recently added to several Russell indexes, including the Russell 1000 Defensive Index and Russell 2500 Index. This shift coul...
RBC Capital analyst Luca Issi lowered the firm’s price target on BioMarin (BMRN) to $62 from $66 and keeps a Sector Perform rating on the shares as part of a br...
Analyst ratings
77%
of 30 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.